Home > Insider Trading > Filing (0000899243-20-017601)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1538927	Forma Therapeutics Holdings Inc.	FMTX	Biological Products, (No Disgnostic Substances) (2836)	371657129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1814683	Paolo Paoletti	C/O Forma Therapeutics Holdings, Inc. 500 Arsenal Street, Suite 100 Watertown MA 02472		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-06-23	45,553	$0.00	45,553	No	4	P	Direct
Enterprise 2 Junior Stock	Disposition	2020-06-23	25,248	$0.00	0	No	4	S	Direct
Enterprise 3 Junior Stock	Disposition	2020-06-23	9,847	$0.00	0	No	4	S	Direct
Enterprise 4 Junior Stock	Disposition	2020-06-23	10,240	$0.00	0	No	4	S	Direct
Enterprise 5 Junior Stock	Disposition	2020-06-23	14,026	$0.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Effective immediately upon the closing of the Registrant's initial public offering on June 23, 2020, the reporting person converted (i) 25,248 shares of Enterprise 2 Junior Stock at a conversion rate of 0.8179 shares of common stock per one share of Enterprise 2 Junior Stock, (ii) 9,847 shares of Enterprise 3 Junior Stock at a conversion rate of 0.7822 shares of common stock per one share of Enterprise 3 Junior Stock, (iii) 10,240 shares of Enterprise 4 Junior Stock at a conversion rate of 0.7585 shares of common stock per one share of Enterprise 4 Junior Stock, and (iv) 14,026 shares of Enterprise 5 Junior Stock at a conversion rate of 0.6727 shares of common stock per one share of Enterprise 5 Junior Stock, resulting in his acquisition of 45,553 shares of common stock.